id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0366-0004,FDA,FDA-2005-P-0366,Petition Approval from FDA/Associate Commissioner for Policy and Planning to Keller and Heckman LLP,Other,Approval,2006-12-18T05:00:00Z,2006,12,,,2025-04-24T18:45:27Z,,0,0,090000648044af45
FDA-2005-P-0366-0003,FDA,FDA-2005-P-0366,FDA/Center for Drug Evaluation and Research to Keller and Heckman LLP - Letter,Other,LET-Letter,2006-06-12T04:00:00Z,2006,6,,,2013-07-27T20:43:33Z,,0,0,090000648044af43